| 000 | 01659 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512005902.0 | ||
| 264 | 0 | _c19900103 | |
| 008 | 199001s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/0014-2999(89)90794-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRooney, K F | |
| 245 | 0 | 0 |
_aEvaluation of selective actions of dopamine D-1 and D-2 receptor agonists and antagonists on opioid antinociception. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cSep 1989 |
||
| 300 |
_a329-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine _xpharmacology |
| 650 | 0 | 4 | _a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDopamine Agents _xpharmacology |
| 650 | 0 | 4 |
_aEnkephalin, Leucine _xanalogs & derivatives |
| 650 | 0 | 4 | _aEnkephalin, Leucine-2-Alanine |
| 650 | 0 | 4 |
_aErgolines _xpharmacology |
| 650 | 0 | 4 |
_aFentanyl _xanalogs & derivatives |
| 650 | 0 | 4 | _aInjections, Intraventricular |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNarcotics _xpharmacology |
| 650 | 0 | 4 |
_aNociceptors _xdrug effects |
| 650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
| 650 | 0 | 4 | _aQuinpirole |
| 650 | 0 | 4 |
_aReaction Time _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
| 650 | 0 | 4 | _aSufentanil |
| 650 | 0 | 4 |
_aSulpiride _xpharmacology |
| 700 | 1 | _aSewell, R D | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 168 _gno. 3 _gp. 329-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(89)90794-2 _zAvailable from publisher's website |
| 999 |
_c2579477 _d2579477 |
||